机构：[1]Department of Thoracic Surgery, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China昆明医科大学附属第一医院[2]Department of Pharmacy, The First Affiliated Hospital of Kunming Medical University,Kunming, Yunnan, China昆明医科大学附属第一医院
The aim of this study was to evaluate effective treatment methods of malignant pleural mesothelioma (MPM). Twenty-three patients with MPM were cured by pleural infusion chemotherapy after surgery. Median survival time and the 1-, 2-, and 3-year survival rates were analyzed on the basis of follow-up. Median survival time of all patients was 15 months (range: 3 to 89 months); the 1-, 2-, and 3-year survival rates were 69.6, 43.5, and 13.0%, respectively. The 1-year survival rates of patients in stages I, II, and III were 83.3, 62.5, and 33.3%, respectively, the 2-year survival rates were 50, 37.5, and 33.3%, respectively, and the 3-year survival rates were 34, 23, and 0%, respectively. Surgery-oriented comprehensive treatment was adopted for MPM, which could improve the prognosis and life quality of patients to some extent.
第一作者机构：[1]Department of Thoracic Surgery, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China
通讯作者：
推荐引用方式(GB/T 7714)：
Zhang J.,Zhang Q.,Zhao W.,et al.Pleural resection and pleural infusion chemotherapy for therapy of malignant pleural mesothelioma[J].GENETICS AND MOLECULAR RESEARCH.2014,13(1):483-489.doi:10.4238/2014.January.21.17.
APA：
Zhang, J.,Zhang, Q.,Zhao, W.,Duan, J.&Huang, T..(2014).Pleural resection and pleural infusion chemotherapy for therapy of malignant pleural mesothelioma.GENETICS AND MOLECULAR RESEARCH,13,(1)
MLA：
Zhang, J.,et al."Pleural resection and pleural infusion chemotherapy for therapy of malignant pleural mesothelioma".GENETICS AND MOLECULAR RESEARCH 13..1(2014):483-489
